Who Owns ImmunityBio Stock?
NASDAQ: IBRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 20.47%
- Held by insiders
- 62.13%
- Institutional holders
- 516
- Institutions 20.5%
- Insiders 62.1%
- Public and other 17.4%
Who owns ImmunityBio stock?
Institutional investors own about 20.5% of ImmunityBio's shares, spread across 516 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 62.13% of IBRX.
The largest institutional holders are Blackrock Inc. (3.40%), State Street Corporation (1.98%) and Vanguard Portfolio Management LLC (1.82%). Together, the top 10 institutions control 13.3% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their IBRX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IBRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 36.12M | 3.40% | +6.0% |
| State Street Corporation | 21.10M | 1.98% | -1.4% |
| Vanguard Portfolio Management LLC | 19.39M | 1.82% | +8.5% |
| Vanguard Capital Management LLC | 18.80M | 1.77% | +19.8% |
| Shaw D.E. & Co., Inc. | 11.55M | 1.09% | -8.1% |
| Two Sigma Investments, LP | 11.10M | 1.04% | +153.0% |
| Geode Capital Management, LLC | 10.61M | 1.00% | +7.7% |
| Millennium Management Llc | 5.58M | 0.52% | +292.9% |
| UBS Group AG | 3.78M | 0.35% | +18.1% |
| Northern Trust Corporation | 3.57M | 0.34% | +42.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IBRX
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 11.70M | 1.10% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 11.60M | 1.09% |
| iShares Trust-iShares Russell 2000 ETF | 9.99M | 0.94% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 8.40M | 0.79% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 4.85M | 0.46% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 4.23M | 0.40% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 3.73M | 0.35% |
| iShares Trust-iShares Russell 2000 Growth ETF | 3.62M | 0.34% |
| iShares Trust-iShares Biotechnology ETF | 3.07M | 0.29% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 2.21M | 0.21% |
Frequently asked questions
Who is the largest shareholder of ImmunityBio?
Blackrock Inc. is the largest institutional shareholder of IBRX, owning 3.40% of shares outstanding (36.12M shares) as of its latest 13F filing.
What percentage of ImmunityBio is owned by institutions?
Institutions own about 20.5% of IBRX shares and 54.1% of the public float.
How much of ImmunityBio do insiders own?
Insiders, such as officers and directors, own about 62.13% of IBRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.